Canine Aβ38 antibody and antigen (recombinant protein)
Diagnostic anti-Canine Aβ38 antibodies pairs and antigen for animal health (animal Dog/Canine Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-AB38-Ag01 | Recombinant Canine Aβ38 protein | 3090 |
GMP-CAN-AB38-Ab01 | Anti-Canine Aβ38 mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-AB38-Ab02 | Anti-Canine Aβ38 mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-AB38-Ab03 | Anti-Canine Aβ38 human monoclonal antibody (mAb) | 1953 |
GMP-CAN-AB38-Ab04 | Anti-Canine Aβ38 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-AB38-Ag01 |
Product Name | Recombinant Canine Aβ38 protein |
Target/Biomarker | Canine beta-amyloid 38 (AIV-A H3N2 subtype) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine beta-amyloid 38 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A H3N2 subtype level test of animal Dog/Canine with Alzheimer Disease(AD). |
Tag | His |
Products description | Recombinant Canine Aβ38 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-AB38-Ab01, GMP-CAN-AB38-Ab02 |
Product Name | Anti-Canine Aβ38 mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine beta-amyloid 38 (AIV-A H3N2 subtype) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine beta-amyloid 38 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H3N2 subtype antibodies in AIV-A H3N2 subtype level test of animal Dog/Canine with Alzheimer Disease(AD). |
Tag | mFc |
Products description | Anti-Canine Aβ38 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H3N2 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-AB38-Ab03, GMP-CAN-AB38-Ab04 |
Product Name | Anti-Canine Aβ38 human monoclonal antibody (mAb) |
Target/Biomarker | Canine beta-amyloid 38 (AIV-A H3N2 subtype) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine beta-amyloid 38 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H3N2 subtype antibodies in AIV-A H3N2 subtype level test of animal Dog/Canine with Alzheimer Disease(AD). |
Tag | hFc |
Products description | Anti-Canine Aβ38 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H3N2 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Canine Aβ38, also known as Amyloid Beta 38, emerges as a pivotal biomarker within the intricate realm of canine cognitive health. This unassuming peptide, a fragment of the amyloid precursor protein (APP), takes center stage in the unfolding drama of cognitive decline in aging dogs. Structurally related to the broader family of amyloid beta peptides, Aβ38 plays a central role in the formation of amyloid plaques within the canine brain, a hallmark of neurodegenerative conditions like canine cognitive dysfunction (CCD). In the complex milieu of the canine central nervous system, Aβ38's story unfolds. It is involved in the generation of amyloid plaques that can accumulate over time, gradually compromising cognitive function and behavior in dogs. CCD, akin to human dementia, casts a shadow on the twilight years of aging canine companions, affecting memory, spatial awareness, and overall cognitive abilities. Understanding Canine Aβ38 is akin to deciphering a critical chapter in the narrative of canine cognitive health. Its presence and levels in the brain offer insights into the progression of neurodegenerative processes in dogs, guiding our comprehension of CCD and related conditions. Monitoring Aβ38 levels equips researchers and veterinarians with a lens through which to observe the course of cognitive decline, helping to unlock potential interventions and therapies aimed at enhancing the quality of life for aging dogs.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.